• Milestone Scientific launched one-time stock option exchange program on April 30, 2026, allowing CEO Eric Hines and SVP Jason Papes to surrender underwater options for new options repriced to $0.31 per share.
• Repriced options cover 2 million shares each, or 4 million shares total, unchanged from options surrendered; original exercise prices ranged from $0.46 to $0.5, with grants dating to August 2025.
• Vesting terms were reset to 500,000 shares on vesting commencement date, with remaining 1.5 million shares vesting in two tranches of 750,000 shares on first and second anniversaries.
• Committee also set performance-based restricted stock unit framework tied to 2026-2029 targets, with up to 17,234,635 shares available on full achievement, subject to stockholder approval to expand share reserve.
• Milestones include organic net sales thresholds of more than $11 million, $13 million, $15 million, plus market capitalization of at least $50 million or a qualified acquisition with more than $10 million of revenue.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Milestone Scientific Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-021506), on May 06, 2026, and is solely responsible for the information contained therein.